nodes	percent_of_prediction	percent_of_DWPC	metapath
Sitaxentan—EDNRB—asthma	0.434	1	CbGaD
Sitaxentan—CYP2C19—Zafirlukast—asthma	0.016	0.05	CbGbCtD
Sitaxentan—CYP2C19—Formoterol—asthma	0.0155	0.0483	CbGbCtD
Sitaxentan—CYP2C19—Arformoterol—asthma	0.0155	0.0483	CbGbCtD
Sitaxentan—CYP2C9—Zileuton—asthma	0.0151	0.0472	CbGbCtD
Sitaxentan—CYP2C9—Zafirlukast—asthma	0.0133	0.0416	CbGbCtD
Sitaxentan—CYP3A4—Fluticasone furoate—asthma	0.013	0.0407	CbGbCtD
Sitaxentan—CYP2C9—Formoterol—asthma	0.0129	0.0402	CbGbCtD
Sitaxentan—CYP2C9—Arformoterol—asthma	0.0129	0.0402	CbGbCtD
Sitaxentan—CYP2C19—Loratadine—asthma	0.0117	0.0366	CbGbCtD
Sitaxentan—CYP3A4—Budesonide—asthma	0.0116	0.0363	CbGbCtD
Sitaxentan—CYP3A4—Ciclesonide—asthma	0.0106	0.0332	CbGbCtD
Sitaxentan—CYP3A4—Indacaterol—asthma	0.0106	0.0332	CbGbCtD
Sitaxentan—CYP2C9—Theophylline—asthma	0.0103	0.0321	CbGbCtD
Sitaxentan—CYP3A4—Salmeterol—asthma	0.00987	0.0308	CbGbCtD
Sitaxentan—CYP3A4—Flunisolide—asthma	0.00987	0.0308	CbGbCtD
Sitaxentan—CYP3A4—Salbutamol—asthma	0.00987	0.0308	CbGbCtD
Sitaxentan—CYP2C9—Montelukast—asthma	0.00974	0.0304	CbGbCtD
Sitaxentan—CYP2C9—Loratadine—asthma	0.00974	0.0304	CbGbCtD
Sitaxentan—CYP3A4—Ipratropium bromide—asthma	0.00879	0.0275	CbGbCtD
Sitaxentan—CYP3A4—Zileuton—asthma	0.00879	0.0275	CbGbCtD
Sitaxentan—CYP3A4—Fluticasone Propionate—asthma	0.00839	0.0262	CbGbCtD
Sitaxentan—CYP3A4—Zafirlukast—asthma	0.00774	0.0242	CbGbCtD
Sitaxentan—CYP3A4—Tiotropium—asthma	0.00666	0.0208	CbGbCtD
Sitaxentan—CYP2C19—Prednisone—asthma	0.00649	0.0203	CbGbCtD
Sitaxentan—CYP3A4—Aminophylline—asthma	0.00636	0.0199	CbGbCtD
Sitaxentan—CYP3A4—Theophylline—asthma	0.00598	0.0187	CbGbCtD
Sitaxentan—CYP3A4—Montelukast—asthma	0.00567	0.0177	CbGbCtD
Sitaxentan—CYP3A4—Loratadine—asthma	0.00567	0.0177	CbGbCtD
Sitaxentan—CYP3A4—Methylprednisolone—asthma	0.00518	0.0162	CbGbCtD
Sitaxentan—CYP2C19—Dexamethasone—asthma	0.00405	0.0127	CbGbCtD
Sitaxentan—CYP3A4—Triamcinolone—asthma	0.00393	0.0123	CbGbCtD
Sitaxentan—CYP2C9—Dexamethasone—asthma	0.00337	0.0105	CbGbCtD
Sitaxentan—CYP3A4—Betamethasone—asthma	0.00337	0.0105	CbGbCtD
Sitaxentan—CYP3A4—Prednisolone—asthma	0.00332	0.0104	CbGbCtD
Sitaxentan—CYP3A4—Hydrocortisone—asthma	0.00315	0.00985	CbGbCtD
Sitaxentan—CYP3A4—Prednisone—asthma	0.00314	0.00981	CbGbCtD
Sitaxentan—CYP3A4—Dexamethasone—asthma	0.00196	0.00612	CbGbCtD
Sitaxentan—EDNRB—adrenal cortex—asthma	0.000821	0.141	CbGeAlD
Sitaxentan—EDNRB—bronchus—asthma	0.000806	0.139	CbGeAlD
Sitaxentan—EDNRA—adrenal cortex—asthma	0.000679	0.117	CbGeAlD
Sitaxentan—EDNRA—bronchus—asthma	0.000666	0.115	CbGeAlD
Sitaxentan—EDNRA—trachea—asthma	0.000598	0.103	CbGeAlD
Sitaxentan—EDNRB—adrenal gland—asthma	0.000593	0.102	CbGeAlD
Sitaxentan—EDNRB—lung—asthma	0.00052	0.0895	CbGeAlD
Sitaxentan—EDNRA—adrenal gland—asthma	0.00049	0.0844	CbGeAlD
Sitaxentan—EDNRA—lung—asthma	0.00043	0.074	CbGeAlD
Sitaxentan—CYP2C9—cardiovascular system—asthma	0.000205	0.0353	CbGeAlD
Sitaxentan—Dizziness—Formoterol—asthma	2.26e-05	0.000147	CcSEcCtD
Sitaxentan—EDNRA—GPCR downstream signaling—EDN1—asthma	2.26e-05	0.000261	CbGpPWpGaD
Sitaxentan—Asthenia—Budesonide—asthma	2.24e-05	0.000146	CcSEcCtD
Sitaxentan—EDNRA—GPCR downstream signaling—CCL5—asthma	2.24e-05	0.000259	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IL2RB—asthma	2.23e-05	0.000258	CbGpPWpGaD
Sitaxentan—Eye disorder—Methylprednisolone—asthma	2.23e-05	0.000146	CcSEcCtD
Sitaxentan—Mental disorder—Hydrocortisone—asthma	2.23e-05	0.000145	CcSEcCtD
Sitaxentan—Cardiac disorder—Methylprednisolone—asthma	2.22e-05	0.000145	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—PDE4D—asthma	2.21e-05	0.000256	CbGpPWpGaD
Sitaxentan—Malnutrition—Hydrocortisone—asthma	2.21e-05	0.000144	CcSEcCtD
Sitaxentan—Dizziness—Montelukast—asthma	2.21e-05	0.000144	CcSEcCtD
Sitaxentan—Bradycardia—Dexamethasone—asthma	2.21e-05	0.000144	CcSEcCtD
Sitaxentan—Bradycardia—Betamethasone—asthma	2.21e-05	0.000144	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—BDKRB2—asthma	2.2e-05	0.000255	CbGpPWpGaD
Sitaxentan—Diarrhoea—Salbutamol—asthma	2.2e-05	0.000144	CcSEcCtD
Sitaxentan—EDNRA—GPCR downstream signaling—CSF2—asthma	2.2e-05	0.000255	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—POMC—asthma	2.2e-05	0.000255	CbGpPWpGaD
Sitaxentan—Haemoglobin—Dexamethasone—asthma	2.18e-05	0.000142	CcSEcCtD
Sitaxentan—Haemoglobin—Betamethasone—asthma	2.18e-05	0.000142	CcSEcCtD
Sitaxentan—Haemorrhage—Dexamethasone—asthma	2.17e-05	0.000142	CcSEcCtD
Sitaxentan—Haemorrhage—Betamethasone—asthma	2.17e-05	0.000142	CcSEcCtD
Sitaxentan—Vomiting—Formoterol—asthma	2.17e-05	0.000142	CcSEcCtD
Sitaxentan—Vomiting—Arformoterol—asthma	2.17e-05	0.000142	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—ITPR1—asthma	2.17e-05	0.000251	CbGpPWpGaD
Sitaxentan—Angiopathy—Methylprednisolone—asthma	2.17e-05	0.000141	CcSEcCtD
Sitaxentan—Nausea—Mometasone—asthma	2.16e-05	0.000141	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—C5—asthma	2.16e-05	0.00025	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—TACR1—asthma	2.16e-05	0.00025	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PDE4B—asthma	2.16e-05	0.00025	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR ligand binding—CXCL8—asthma	2.16e-05	0.000249	CbGpPWpGaD
Sitaxentan—Immune system disorder—Methylprednisolone—asthma	2.16e-05	0.000141	CcSEcCtD
Sitaxentan—Rash—Arformoterol—asthma	2.15e-05	0.00014	CcSEcCtD
Sitaxentan—Rash—Formoterol—asthma	2.15e-05	0.00014	CcSEcCtD
Sitaxentan—Mediastinal disorder—Methylprednisolone—asthma	2.15e-05	0.00014	CcSEcCtD
Sitaxentan—Dermatitis—Formoterol—asthma	2.15e-05	0.00014	CcSEcCtD
Sitaxentan—Dermatitis—Arformoterol—asthma	2.15e-05	0.00014	CcSEcCtD
Sitaxentan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—asthma	2.15e-05	0.000249	CbGpPWpGaD
Sitaxentan—CYP2C19—Biological oxidations—GSTP1—asthma	2.15e-05	0.000248	CbGpPWpGaD
Sitaxentan—Headache—Arformoterol—asthma	2.14e-05	0.000139	CcSEcCtD
Sitaxentan—Headache—Formoterol—asthma	2.14e-05	0.000139	CcSEcCtD
Sitaxentan—Weight decreased—Prednisone—asthma	2.14e-05	0.000139	CcSEcCtD
Sitaxentan—Diarrhoea—Budesonide—asthma	2.14e-05	0.000139	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—ADCY2—asthma	2.13e-05	0.000247	CbGpPWpGaD
Sitaxentan—Dizziness—Salbutamol—asthma	2.13e-05	0.000139	CcSEcCtD
Sitaxentan—Hyperglycaemia—Prednisone—asthma	2.13e-05	0.000139	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—IL3—asthma	2.13e-05	0.000246	CbGpPWpGaD
Sitaxentan—Vomiting—Montelukast—asthma	2.13e-05	0.000139	CcSEcCtD
Sitaxentan—CYP2C19—Metapathway biotransformation—GSTP1—asthma	2.12e-05	0.000245	CbGpPWpGaD
Sitaxentan—Rash—Montelukast—asthma	2.11e-05	0.000137	CcSEcCtD
Sitaxentan—Dermatitis—Montelukast—asthma	2.11e-05	0.000137	CcSEcCtD
Sitaxentan—Ill-defined disorder—Prednisolone—asthma	2.1e-05	0.000137	CcSEcCtD
Sitaxentan—Headache—Montelukast—asthma	2.09e-05	0.000137	CcSEcCtD
Sitaxentan—Visual impairment—Betamethasone—asthma	2.09e-05	0.000136	CcSEcCtD
Sitaxentan—Visual impairment—Dexamethasone—asthma	2.09e-05	0.000136	CcSEcCtD
Sitaxentan—Mental disorder—Methylprednisolone—asthma	2.09e-05	0.000136	CcSEcCtD
Sitaxentan—Malnutrition—Methylprednisolone—asthma	2.08e-05	0.000136	CcSEcCtD
Sitaxentan—Acute coronary syndrome—Prednisone—asthma	2.08e-05	0.000135	CcSEcCtD
Sitaxentan—Myocardial infarction—Prednisone—asthma	2.06e-05	0.000135	CcSEcCtD
Sitaxentan—Dizziness—Budesonide—asthma	2.06e-05	0.000135	CcSEcCtD
Sitaxentan—Ill-defined disorder—Hydrocortisone—asthma	2.05e-05	0.000134	CcSEcCtD
Sitaxentan—Vomiting—Salbutamol—asthma	2.05e-05	0.000134	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—EDN1—asthma	2.05e-05	0.000237	CbGpPWpGaD
Sitaxentan—Malaise—Prednisolone—asthma	2.04e-05	0.000133	CcSEcCtD
Sitaxentan—Vertigo—Prednisolone—asthma	2.03e-05	0.000133	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—CCL5—asthma	2.03e-05	0.000235	CbGpPWpGaD
Sitaxentan—Rash—Salbutamol—asthma	2.03e-05	0.000133	CcSEcCtD
Sitaxentan—Dermatitis—Salbutamol—asthma	2.03e-05	0.000132	CcSEcCtD
Sitaxentan—Eye disorder—Betamethasone—asthma	2.03e-05	0.000132	CcSEcCtD
Sitaxentan—Eye disorder—Dexamethasone—asthma	2.03e-05	0.000132	CcSEcCtD
Sitaxentan—Nausea—Arformoterol—asthma	2.03e-05	0.000132	CcSEcCtD
Sitaxentan—Nausea—Formoterol—asthma	2.03e-05	0.000132	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—PLA2G4A—asthma	2.02e-05	0.000234	CbGpPWpGaD
Sitaxentan—Headache—Salbutamol—asthma	2.02e-05	0.000132	CcSEcCtD
Sitaxentan—EDNRA—GPCR downstream signaling—CCR5—asthma	2.02e-05	0.000233	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—KNG1—asthma	2.01e-05	0.000232	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—CSF2—asthma	2e-05	0.000232	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—POMC—asthma	2e-05	0.000231	CbGpPWpGaD
Sitaxentan—Malaise—Hydrocortisone—asthma	1.99e-05	0.00013	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—AGTR1—asthma	1.99e-05	0.000231	CbGpPWpGaD
Sitaxentan—Vertigo—Hydrocortisone—asthma	1.99e-05	0.00013	CcSEcCtD
Sitaxentan—EDNRA—GPCR downstream signaling—IL2RA—asthma	1.99e-05	0.00023	CbGpPWpGaD
Sitaxentan—Nausea—Montelukast—asthma	1.99e-05	0.00013	CcSEcCtD
Sitaxentan—Vomiting—Budesonide—asthma	1.98e-05	0.000129	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—CCR3—asthma	1.97e-05	0.000228	CbGpPWpGaD
Sitaxentan—CYP2C19—Biological oxidations—GSTM1—asthma	1.97e-05	0.000228	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—C3—asthma	1.97e-05	0.000228	CbGpPWpGaD
Sitaxentan—Angiopathy—Dexamethasone—asthma	1.97e-05	0.000128	CcSEcCtD
Sitaxentan—Angiopathy—Betamethasone—asthma	1.97e-05	0.000128	CcSEcCtD
Sitaxentan—Rash—Budesonide—asthma	1.97e-05	0.000128	CcSEcCtD
Sitaxentan—Dermatitis—Budesonide—asthma	1.97e-05	0.000128	CcSEcCtD
Sitaxentan—CYP3A4—Biological oxidations—ALDH2—asthma	1.96e-05	0.000227	CbGpPWpGaD
Sitaxentan—CYP2C9—Biological oxidations—GSTP1—asthma	1.96e-05	0.000226	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—CCL2—asthma	1.96e-05	0.000226	CbGpPWpGaD
Sitaxentan—Headache—Budesonide—asthma	1.96e-05	0.000128	CcSEcCtD
Sitaxentan—EDNRB—Signaling by GPCR—IL6R—asthma	1.95e-05	0.000226	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—CXCL10—asthma	1.95e-05	0.000225	CbGpPWpGaD
Sitaxentan—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—asthma	1.95e-05	0.000225	CbGpPWpGaD
Sitaxentan—CYP2C19—Metapathway biotransformation—GSTM1—asthma	1.95e-05	0.000225	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—RHOA—asthma	1.94e-05	0.000224	CbGpPWpGaD
Sitaxentan—Ill-defined disorder—Triamcinolone—asthma	1.93e-05	0.000126	CcSEcCtD
Sitaxentan—CYP2C9—Metapathway biotransformation—GSTP1—asthma	1.93e-05	0.000223	CbGpPWpGaD
Sitaxentan—Ill-defined disorder—Methylprednisolone—asthma	1.93e-05	0.000126	CcSEcCtD
Sitaxentan—Bradycardia—Prednisone—asthma	1.92e-05	0.000126	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—NPY—asthma	1.92e-05	0.000222	CbGpPWpGaD
Sitaxentan—Alopecia—Betamethasone—asthma	1.92e-05	0.000125	CcSEcCtD
Sitaxentan—Alopecia—Dexamethasone—asthma	1.92e-05	0.000125	CcSEcCtD
Sitaxentan—Nausea—Salbutamol—asthma	1.91e-05	0.000125	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—NTRK1—asthma	1.91e-05	0.000221	CbGpPWpGaD
Sitaxentan—Discomfort—Prednisolone—asthma	1.9e-05	0.000124	CcSEcCtD
Sitaxentan—Haemoglobin—Prednisone—asthma	1.9e-05	0.000124	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—ADRB2—asthma	1.89e-05	0.000219	CbGpPWpGaD
Sitaxentan—Haemorrhage—Prednisone—asthma	1.89e-05	0.000123	CcSEcCtD
Sitaxentan—Malaise—Triamcinolone—asthma	1.88e-05	0.000123	CcSEcCtD
Sitaxentan—Malaise—Methylprednisolone—asthma	1.87e-05	0.000122	CcSEcCtD
Sitaxentan—Vertigo—Triamcinolone—asthma	1.87e-05	0.000122	CcSEcCtD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	1.87e-05	0.000122	CcSEcCtD
Sitaxentan—Vertigo—Methylprednisolone—asthma	1.87e-05	0.000122	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—PPP2CA—asthma	1.86e-05	0.000216	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—GSTT1—asthma	1.86e-05	0.000215	CbGpPWpGaD
Sitaxentan—Discomfort—Hydrocortisone—asthma	1.86e-05	0.000121	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—AGTR2—asthma	1.86e-05	0.000215	CbGpPWpGaD
Sitaxentan—Nausea—Budesonide—asthma	1.85e-05	0.000121	CcSEcCtD
Sitaxentan—Oedema—Prednisolone—asthma	1.85e-05	0.000121	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—CCR5—asthma	1.83e-05	0.000212	CbGpPWpGaD
Sitaxentan—Oedema—Hydrocortisone—asthma	1.8e-05	0.000118	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—IL2RA—asthma	1.8e-05	0.000209	CbGpPWpGaD
Sitaxentan—Tachycardia—Prednisolone—asthma	1.8e-05	0.000118	CcSEcCtD
Sitaxentan—CYP2C9—Biological oxidations—GSTM1—asthma	1.8e-05	0.000208	CbGpPWpGaD
Sitaxentan—Infection—Hydrocortisone—asthma	1.79e-05	0.000117	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—ITPR1—asthma	1.79e-05	0.000207	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—C3—asthma	1.79e-05	0.000207	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—EDNRB—asthma	1.78e-05	0.000206	CbGpPWpGaD
Sitaxentan—CYP2C9—Metapathway biotransformation—GSTM1—asthma	1.77e-05	0.000205	CbGpPWpGaD
Sitaxentan—Nervous system disorder—Hydrocortisone—asthma	1.77e-05	0.000115	CcSEcCtD
Sitaxentan—Eye disorder—Prednisone—asthma	1.77e-05	0.000115	CcSEcCtD
Sitaxentan—EDNRB—Signaling by GPCR—RHOA—asthma	1.76e-05	0.000204	CbGpPWpGaD
Sitaxentan—Tachycardia—Hydrocortisone—asthma	1.76e-05	0.000115	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—NPS—asthma	1.76e-05	0.000203	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—TAC1—asthma	1.76e-05	0.000203	CbGpPWpGaD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	1.76e-05	0.000115	CcSEcCtD
Sitaxentan—Flushing—Prednisone—asthma	1.75e-05	0.000114	CcSEcCtD
Sitaxentan—Skin disorder—Hydrocortisone—asthma	1.75e-05	0.000114	CcSEcCtD
Sitaxentan—Ill-defined disorder—Betamethasone—asthma	1.75e-05	0.000114	CcSEcCtD
Sitaxentan—Ill-defined disorder—Dexamethasone—asthma	1.75e-05	0.000114	CcSEcCtD
Sitaxentan—Discomfort—Triamcinolone—asthma	1.75e-05	0.000114	CcSEcCtD
Sitaxentan—Discomfort—Methylprednisolone—asthma	1.75e-05	0.000114	CcSEcCtD
Sitaxentan—Dry mouth—Triamcinolone—asthma	1.73e-05	0.000113	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—CXCR3—asthma	1.73e-05	0.0002	CbGpPWpGaD
Sitaxentan—Anorexia—Hydrocortisone—asthma	1.72e-05	0.000112	CcSEcCtD
Sitaxentan—Angiopathy—Prednisone—asthma	1.71e-05	0.000112	CcSEcCtD
Sitaxentan—Confusional state—Methylprednisolone—asthma	1.71e-05	0.000112	CcSEcCtD
Sitaxentan—Immune system disorder—Prednisone—asthma	1.71e-05	0.000111	CcSEcCtD
Sitaxentan—Malaise—Dexamethasone—asthma	1.7e-05	0.000111	CcSEcCtD
Sitaxentan—Malaise—Betamethasone—asthma	1.7e-05	0.000111	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—CD86—asthma	1.7e-05	0.000197	CbGpPWpGaD
Sitaxentan—EDNRB—GPCR downstream signaling—CXCL8—asthma	1.7e-05	0.000197	CbGpPWpGaD
Sitaxentan—Oedema—Triamcinolone—asthma	1.7e-05	0.000111	CcSEcCtD
Sitaxentan—Vertigo—Dexamethasone—asthma	1.7e-05	0.000111	CcSEcCtD
Sitaxentan—Vertigo—Betamethasone—asthma	1.7e-05	0.000111	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—EDN1—asthma	1.69e-05	0.000196	CbGpPWpGaD
Sitaxentan—Infection—Triamcinolone—asthma	1.69e-05	0.00011	CcSEcCtD
Sitaxentan—Hypotension—Hydrocortisone—asthma	1.69e-05	0.00011	CcSEcCtD
Sitaxentan—Infection—Methylprednisolone—asthma	1.68e-05	0.00011	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—CCL5—asthma	1.68e-05	0.000194	CbGpPWpGaD
Sitaxentan—Insomnia—Prednisolone—asthma	1.67e-05	0.000109	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—CYBA—asthma	1.67e-05	0.000193	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—PLA2G4A—asthma	1.67e-05	0.000193	CbGpPWpGaD
Sitaxentan—Alopecia—Prednisone—asthma	1.67e-05	0.000109	CcSEcCtD
Sitaxentan—Nervous system disorder—Methylprednisolone—asthma	1.66e-05	0.000108	CcSEcCtD
Sitaxentan—Tachycardia—Triamcinolone—asthma	1.66e-05	0.000108	CcSEcCtD
Sitaxentan—Mental disorder—Prednisone—asthma	1.66e-05	0.000108	CcSEcCtD
Sitaxentan—Tachycardia—Methylprednisolone—asthma	1.65e-05	0.000108	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—CSF2—asthma	1.65e-05	0.000191	CbGpPWpGaD
Sitaxentan—Skin disorder—Methylprednisolone—asthma	1.65e-05	0.000107	CcSEcCtD
Sitaxentan—Malnutrition—Prednisone—asthma	1.65e-05	0.000107	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—IL5—asthma	1.64e-05	0.000189	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PARP1—asthma	1.64e-05	0.000189	CbGpPWpGaD
Sitaxentan—Insomnia—Hydrocortisone—asthma	1.63e-05	0.000107	CcSEcCtD
Sitaxentan—EDNRB—GPCR downstream signaling—IL2—asthma	1.63e-05	0.000188	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—SMAD3—asthma	1.61e-05	0.000186	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—ALOX15—asthma	1.61e-05	0.000186	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5AP—asthma	1.61e-05	0.000186	CbGpPWpGaD
Sitaxentan—Discomfort—Dexamethasone—asthma	1.59e-05	0.000104	CcSEcCtD
Sitaxentan—Discomfort—Betamethasone—asthma	1.59e-05	0.000104	CcSEcCtD
Sitaxentan—Dyspepsia—Hydrocortisone—asthma	1.59e-05	0.000104	CcSEcCtD
Sitaxentan—Hypotension—Methylprednisolone—asthma	1.58e-05	0.000103	CcSEcCtD
Sitaxentan—Pain—Prednisolone—asthma	1.58e-05	0.000103	CcSEcCtD
Sitaxentan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—asthma	1.58e-05	0.000183	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—BDKRB2—asthma	1.58e-05	0.000183	CbGpPWpGaD
Sitaxentan—EDNRA—GPCR downstream signaling—POMC—asthma	1.58e-05	0.000182	CbGpPWpGaD
Sitaxentan—Decreased appetite—Hydrocortisone—asthma	1.57e-05	0.000102	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Hydrocortisone—asthma	1.56e-05	0.000102	CcSEcCtD
Sitaxentan—Fatigue—Hydrocortisone—asthma	1.56e-05	0.000102	CcSEcCtD
Sitaxentan—EDNRB—Signaling by GPCR—CXCL8—asthma	1.55e-05	0.000179	CbGpPWpGaD
Sitaxentan—Pain—Hydrocortisone—asthma	1.54e-05	0.000101	CcSEcCtD
Sitaxentan—Oedema—Betamethasone—asthma	1.54e-05	0.000101	CcSEcCtD
Sitaxentan—Oedema—Dexamethasone—asthma	1.54e-05	0.000101	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—PPP2CA—asthma	1.54e-05	0.000178	CbGpPWpGaD
Sitaxentan—Insomnia—Triamcinolone—asthma	1.54e-05	0.0001	CcSEcCtD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—asthma	1.53e-05	0.000177	CbGpPWpGaD
Sitaxentan—Insomnia—Methylprednisolone—asthma	1.53e-05	0.0001	CcSEcCtD
Sitaxentan—Infection—Betamethasone—asthma	1.53e-05	0.0001	CcSEcCtD
Sitaxentan—Infection—Dexamethasone—asthma	1.53e-05	0.0001	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—ADCY2—asthma	1.53e-05	0.000177	CbGpPWpGaD
Sitaxentan—Ill-defined disorder—Prednisone—asthma	1.53e-05	9.96e-05	CcSEcCtD
Sitaxentan—Feeling abnormal—Prednisolone—asthma	1.52e-05	9.94e-05	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—IL3—asthma	1.52e-05	0.000176	CbGpPWpGaD
Sitaxentan—Anaemia—Prednisone—asthma	1.52e-05	9.92e-05	CcSEcCtD
Sitaxentan—Nervous system disorder—Betamethasone—asthma	1.51e-05	9.87e-05	CcSEcCtD
Sitaxentan—Nervous system disorder—Dexamethasone—asthma	1.51e-05	9.87e-05	CcSEcCtD
Sitaxentan—Agitation—Prednisone—asthma	1.51e-05	9.87e-05	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—CCR5—asthma	1.51e-05	0.000175	CbGpPWpGaD
Sitaxentan—Thrombocytopenia—Dexamethasone—asthma	1.51e-05	9.85e-05	CcSEcCtD
Sitaxentan—Thrombocytopenia—Betamethasone—asthma	1.51e-05	9.85e-05	CcSEcCtD
Sitaxentan—Tachycardia—Dexamethasone—asthma	1.5e-05	9.82e-05	CcSEcCtD
Sitaxentan—Tachycardia—Betamethasone—asthma	1.5e-05	9.82e-05	CcSEcCtD
Sitaxentan—Dyspepsia—Triamcinolone—asthma	1.5e-05	9.76e-05	CcSEcCtD
Sitaxentan—Dyspepsia—Methylprednisolone—asthma	1.49e-05	9.74e-05	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—IL2RA—asthma	1.49e-05	0.000172	CbGpPWpGaD
Sitaxentan—Feeling abnormal—Hydrocortisone—asthma	1.49e-05	9.7e-05	CcSEcCtD
Sitaxentan—Malaise—Prednisone—asthma	1.48e-05	9.68e-05	CcSEcCtD
Sitaxentan—Vertigo—Prednisone—asthma	1.48e-05	9.65e-05	CcSEcCtD
Sitaxentan—EDNRB—Signaling by GPCR—IL2—asthma	1.48e-05	0.000171	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—C3—asthma	1.48e-05	0.000171	CbGpPWpGaD
Sitaxentan—Anorexia—Betamethasone—asthma	1.47e-05	9.59e-05	CcSEcCtD
Sitaxentan—Anorexia—Dexamethasone—asthma	1.47e-05	9.59e-05	CcSEcCtD
Sitaxentan—Urticaria—Prednisolone—asthma	1.47e-05	9.58e-05	CcSEcCtD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5AP—asthma	1.47e-05	0.00017	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—asthma	1.47e-05	0.00017	CbGpPWpGaD
Sitaxentan—Fatigue—Triamcinolone—asthma	1.47e-05	9.56e-05	CcSEcCtD
Sitaxentan—Fatigue—Methylprednisolone—asthma	1.46e-05	9.54e-05	CcSEcCtD
Sitaxentan—Pain—Triamcinolone—asthma	1.45e-05	9.48e-05	CcSEcCtD
Sitaxentan—Hypotension—Betamethasone—asthma	1.44e-05	9.4e-05	CcSEcCtD
Sitaxentan—Hypotension—Dexamethasone—asthma	1.44e-05	9.4e-05	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—PDGFB—asthma	1.44e-05	0.000166	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—KNG1—asthma	1.44e-05	0.000166	CbGpPWpGaD
Sitaxentan—Urticaria—Hydrocortisone—asthma	1.43e-05	9.35e-05	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—POMC—asthma	1.43e-05	0.000165	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—AGTR1—asthma	1.43e-05	0.000165	CbGpPWpGaD
Sitaxentan—Body temperature increased—Hydrocortisone—asthma	1.43e-05	9.31e-05	CcSEcCtD
Sitaxentan—Feeling abnormal—Triamcinolone—asthma	1.4e-05	9.14e-05	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—CCL2—asthma	1.4e-05	0.000162	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—asthma	1.4e-05	0.000162	CbGpPWpGaD
Sitaxentan—Feeling abnormal—Methylprednisolone—asthma	1.4e-05	9.12e-05	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—IL6R—asthma	1.4e-05	0.000161	CbGpPWpGaD
Sitaxentan—Insomnia—Dexamethasone—asthma	1.39e-05	9.1e-05	CcSEcCtD
Sitaxentan—Insomnia—Betamethasone—asthma	1.39e-05	9.1e-05	CcSEcCtD
Sitaxentan—CYP2C19—Biological oxidations—POMC—asthma	1.39e-05	0.000161	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CXCL10—asthma	1.39e-05	0.000161	CbGpPWpGaD
Sitaxentan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	1.39e-05	9.08e-05	CcSEcCtD
Sitaxentan—EDNRA—GPCR downstream signaling—RHOA—asthma	1.39e-05	0.000161	CbGpPWpGaD
Sitaxentan—Discomfort—Prednisone—asthma	1.38e-05	9.03e-05	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—LEP—asthma	1.37e-05	0.000159	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NTRK1—asthma	1.37e-05	0.000158	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5—asthma	1.37e-05	0.000158	CbGpPWpGaD
Sitaxentan—Hypersensitivity—Prednisolone—asthma	1.36e-05	8.88e-05	CcSEcCtD
Sitaxentan—Dyspepsia—Betamethasone—asthma	1.36e-05	8.86e-05	CcSEcCtD
Sitaxentan—Dyspepsia—Dexamethasone—asthma	1.36e-05	8.86e-05	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—ADRB2—asthma	1.35e-05	0.000157	CbGpPWpGaD
Sitaxentan—Urticaria—Triamcinolone—asthma	1.35e-05	8.81e-05	CcSEcCtD
Sitaxentan—Urticaria—Methylprednisolone—asthma	1.35e-05	8.79e-05	CcSEcCtD
Sitaxentan—Body temperature increased—Triamcinolone—asthma	1.34e-05	8.77e-05	CcSEcCtD
Sitaxentan—Oedema—Prednisone—asthma	1.34e-05	8.76e-05	CcSEcCtD
Sitaxentan—Decreased appetite—Dexamethasone—asthma	1.34e-05	8.75e-05	CcSEcCtD
Sitaxentan—Decreased appetite—Betamethasone—asthma	1.34e-05	8.75e-05	CcSEcCtD
Sitaxentan—Infection—Prednisone—asthma	1.33e-05	8.7e-05	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Dexamethasone—asthma	1.33e-05	8.69e-05	CcSEcCtD
Sitaxentan—Gastrointestinal disorder—Betamethasone—asthma	1.33e-05	8.69e-05	CcSEcCtD
Sitaxentan—Hypersensitivity—Hydrocortisone—asthma	1.33e-05	8.68e-05	CcSEcCtD
Sitaxentan—Fatigue—Dexamethasone—asthma	1.33e-05	8.67e-05	CcSEcCtD
Sitaxentan—Fatigue—Betamethasone—asthma	1.33e-05	8.67e-05	CcSEcCtD
Sitaxentan—Pain—Betamethasone—asthma	1.32e-05	8.6e-05	CcSEcCtD
Sitaxentan—Pain—Dexamethasone—asthma	1.32e-05	8.6e-05	CcSEcCtD
Sitaxentan—Nervous system disorder—Prednisone—asthma	1.32e-05	8.59e-05	CcSEcCtD
Sitaxentan—CYP2C19—Metabolism—LTC4S—asthma	1.32e-05	0.000152	CbGpPWpGaD
Sitaxentan—Tachycardia—Prednisone—asthma	1.31e-05	8.55e-05	CcSEcCtD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—asthma	1.3e-05	0.000151	CbGpPWpGaD
Sitaxentan—Skin disorder—Prednisone—asthma	1.3e-05	8.51e-05	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—FN1—asthma	1.3e-05	0.00015	CbGpPWpGaD
Sitaxentan—Asthenia—Hydrocortisone—asthma	1.29e-05	8.45e-05	CcSEcCtD
Sitaxentan—CYP3A4—Biological oxidations—GSTP1—asthma	1.29e-05	0.000149	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—ITPR1—asthma	1.28e-05	0.000148	CbGpPWpGaD
Sitaxentan—Anorexia—Prednisone—asthma	1.28e-05	8.35e-05	CcSEcCtD
Sitaxentan—CYP3A4—Metapathway biotransformation—GSTP1—asthma	1.27e-05	0.000147	CbGpPWpGaD
Sitaxentan—CYP2C9—Biological oxidations—POMC—asthma	1.27e-05	0.000147	CbGpPWpGaD
Sitaxentan—Feeling abnormal—Dexamethasone—asthma	1.27e-05	8.29e-05	CcSEcCtD
Sitaxentan—Feeling abnormal—Betamethasone—asthma	1.27e-05	8.29e-05	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—RHOA—asthma	1.26e-05	0.000146	CbGpPWpGaD
Sitaxentan—Hypersensitivity—Triamcinolone—asthma	1.25e-05	8.17e-05	CcSEcCtD
Sitaxentan—Hypersensitivity—Methylprednisolone—asthma	1.25e-05	8.15e-05	CcSEcCtD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—asthma	1.25e-05	0.000144	CbGpPWpGaD
Sitaxentan—Diarrhoea—Hydrocortisone—asthma	1.23e-05	8.06e-05	CcSEcCtD
Sitaxentan—Urticaria—Betamethasone—asthma	1.23e-05	7.99e-05	CcSEcCtD
Sitaxentan—Urticaria—Dexamethasone—asthma	1.23e-05	7.99e-05	CcSEcCtD
Sitaxentan—Dizziness—Prednisolone—asthma	1.22e-05	7.97e-05	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—CD86—asthma	1.22e-05	0.000141	CbGpPWpGaD
Sitaxentan—Asthenia—Triamcinolone—asthma	1.22e-05	7.96e-05	CcSEcCtD
Sitaxentan—Body temperature increased—Betamethasone—asthma	1.22e-05	7.95e-05	CcSEcCtD
Sitaxentan—Body temperature increased—Dexamethasone—asthma	1.22e-05	7.95e-05	CcSEcCtD
Sitaxentan—EDNRA—GPCR downstream signaling—CXCL8—asthma	1.22e-05	0.000141	CbGpPWpGaD
Sitaxentan—Asthenia—Methylprednisolone—asthma	1.22e-05	7.94e-05	CcSEcCtD
Sitaxentan—Insomnia—Prednisone—asthma	1.21e-05	7.92e-05	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—EDN1—asthma	1.21e-05	0.00014	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CCL5—asthma	1.2e-05	0.000139	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—LTC4S—asthma	1.2e-05	0.000139	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PLA2G4A—asthma	1.2e-05	0.000138	CbGpPWpGaD
Sitaxentan—Dizziness—Hydrocortisone—asthma	1.19e-05	7.79e-05	CcSEcCtD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—asthma	1.19e-05	0.000138	CbGpPWpGaD
Sitaxentan—CYP3A4—Biological oxidations—GSTM1—asthma	1.19e-05	0.000137	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CSF2—asthma	1.18e-05	0.000137	CbGpPWpGaD
Sitaxentan—Dyspepsia—Prednisone—asthma	1.18e-05	7.71e-05	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—POMC—asthma	1.18e-05	0.000137	CbGpPWpGaD
Sitaxentan—CYP3A4—Metapathway biotransformation—GSTM1—asthma	1.17e-05	0.000135	CbGpPWpGaD
Sitaxentan—Decreased appetite—Prednisone—asthma	1.17e-05	7.62e-05	CcSEcCtD
Sitaxentan—Rash—Prednisolone—asthma	1.17e-05	7.6e-05	CcSEcCtD
Sitaxentan—EDNRA—GPCR downstream signaling—IL2—asthma	1.16e-05	0.000135	CbGpPWpGaD
Sitaxentan—Dermatitis—Prednisolone—asthma	1.16e-05	7.6e-05	CcSEcCtD
Sitaxentan—Diarrhoea—Methylprednisolone—asthma	1.16e-05	7.57e-05	CcSEcCtD
Sitaxentan—Fatigue—Prednisone—asthma	1.16e-05	7.55e-05	CcSEcCtD
Sitaxentan—Headache—Prednisolone—asthma	1.16e-05	7.55e-05	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—CCL2—asthma	1.16e-05	0.000134	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IL6R—asthma	1.15e-05	0.000133	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—SMAD3—asthma	1.15e-05	0.000133	CbGpPWpGaD
Sitaxentan—Constipation—Prednisone—asthma	1.15e-05	7.49e-05	CcSEcCtD
Sitaxentan—Vomiting—Hydrocortisone—asthma	1.15e-05	7.49e-05	CcSEcCtD
Sitaxentan—CYP2C19—Metabolism—LTA4H—asthma	1.14e-05	0.000132	CbGpPWpGaD
Sitaxentan—Rash—Hydrocortisone—asthma	1.14e-05	7.42e-05	CcSEcCtD
Sitaxentan—Dermatitis—Hydrocortisone—asthma	1.14e-05	7.42e-05	CcSEcCtD
Sitaxentan—Headache—Hydrocortisone—asthma	1.13e-05	7.38e-05	CcSEcCtD
Sitaxentan—EDNRB—Signaling by GPCR—EGFR—asthma	1.13e-05	0.000131	CbGpPWpGaD
Sitaxentan—Dizziness—Triamcinolone—asthma	1.12e-05	7.33e-05	CcSEcCtD
Sitaxentan—Dizziness—Methylprednisolone—asthma	1.12e-05	7.32e-05	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—CXCL8—asthma	1.11e-05	0.000128	CbGpPWpGaD
Sitaxentan—Feeling abnormal—Prednisone—asthma	1.11e-05	7.22e-05	CcSEcCtD
Sitaxentan—Asthenia—Dexamethasone—asthma	1.11e-05	7.22e-05	CcSEcCtD
Sitaxentan—Asthenia—Betamethasone—asthma	1.11e-05	7.22e-05	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—PPP2CA—asthma	1.1e-05	0.000127	CbGpPWpGaD
Sitaxentan—Nausea—Prednisolone—asthma	1.1e-05	7.16e-05	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—CCR5—asthma	1.08e-05	0.000125	CbGpPWpGaD
Sitaxentan—Vomiting—Triamcinolone—asthma	1.08e-05	7.05e-05	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—SERPINE1—asthma	1.08e-05	0.000125	CbGpPWpGaD
Sitaxentan—Vomiting—Methylprednisolone—asthma	1.08e-05	7.03e-05	CcSEcCtD
Sitaxentan—Nausea—Hydrocortisone—asthma	1.07e-05	6.99e-05	CcSEcCtD
Sitaxentan—Rash—Triamcinolone—asthma	1.07e-05	6.99e-05	CcSEcCtD
Sitaxentan—Dermatitis—Triamcinolone—asthma	1.07e-05	6.98e-05	CcSEcCtD
Sitaxentan—Rash—Methylprednisolone—asthma	1.07e-05	6.98e-05	CcSEcCtD
Sitaxentan—Dermatitis—Methylprednisolone—asthma	1.07e-05	6.97e-05	CcSEcCtD
Sitaxentan—Urticaria—Prednisone—asthma	1.07e-05	6.96e-05	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—IL2RA—asthma	1.07e-05	0.000123	CbGpPWpGaD
Sitaxentan—Headache—Triamcinolone—asthma	1.06e-05	6.95e-05	CcSEcCtD
Sitaxentan—Headache—Methylprednisolone—asthma	1.06e-05	6.93e-05	CcSEcCtD
Sitaxentan—Body temperature increased—Prednisone—asthma	1.06e-05	6.93e-05	CcSEcCtD
Sitaxentan—EDNRA—Signaling by GPCR—IL2—asthma	1.06e-05	0.000122	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—C3—asthma	1.06e-05	0.000122	CbGpPWpGaD
Sitaxentan—Diarrhoea—Betamethasone—asthma	1.06e-05	6.88e-05	CcSEcCtD
Sitaxentan—Diarrhoea—Dexamethasone—asthma	1.06e-05	6.88e-05	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—RHOA—asthma	1.04e-05	0.00012	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—LTA4H—asthma	1.04e-05	0.00012	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—NOS3—asthma	1.03e-05	0.000119	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PDGFB—asthma	1.03e-05	0.000119	CbGpPWpGaD
Sitaxentan—Dizziness—Betamethasone—asthma	1.02e-05	6.65e-05	CcSEcCtD
Sitaxentan—Dizziness—Dexamethasone—asthma	1.02e-05	6.65e-05	CcSEcCtD
Sitaxentan—Nausea—Triamcinolone—asthma	1.01e-05	6.59e-05	CcSEcCtD
Sitaxentan—Nausea—Methylprednisolone—asthma	1.01e-05	6.57e-05	CcSEcCtD
Sitaxentan—CYP2C19—Metabolism—ARG1—asthma	9.97e-06	0.000115	CbGpPWpGaD
Sitaxentan—Hypersensitivity—Prednisone—asthma	9.89e-06	6.46e-05	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—LEP—asthma	9.84e-06	0.000114	CbGpPWpGaD
Sitaxentan—Vomiting—Betamethasone—asthma	9.8e-06	6.4e-05	CcSEcCtD
Sitaxentan—Vomiting—Dexamethasone—asthma	9.8e-06	6.4e-05	CcSEcCtD
Sitaxentan—Rash—Dexamethasone—asthma	9.72e-06	6.34e-05	CcSEcCtD
Sitaxentan—Rash—Betamethasone—asthma	9.72e-06	6.34e-05	CcSEcCtD
Sitaxentan—Dermatitis—Dexamethasone—asthma	9.71e-06	6.34e-05	CcSEcCtD
Sitaxentan—Dermatitis—Betamethasone—asthma	9.71e-06	6.34e-05	CcSEcCtD
Sitaxentan—Headache—Dexamethasone—asthma	9.66e-06	6.3e-05	CcSEcCtD
Sitaxentan—Headache—Betamethasone—asthma	9.66e-06	6.3e-05	CcSEcCtD
Sitaxentan—Asthenia—Prednisone—asthma	9.64e-06	6.29e-05	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—FN1—asthma	9.28e-06	0.000107	CbGpPWpGaD
Sitaxentan—Diarrhoea—Prednisone—asthma	9.19e-06	5.99e-05	CcSEcCtD
Sitaxentan—Nausea—Dexamethasone—asthma	9.16e-06	5.98e-05	CcSEcCtD
Sitaxentan—Nausea—Betamethasone—asthma	9.16e-06	5.98e-05	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—CXCL8—asthma	9.14e-06	0.000106	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ARG1—asthma	9.09e-06	0.000105	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ALDH7A1—asthma	9.02e-06	0.000104	CbGpPWpGaD
Sitaxentan—Dizziness—Prednisone—asthma	8.88e-06	5.79e-05	CcSEcCtD
Sitaxentan—EDNRB—Signaling Pathways—IL2—asthma	8.73e-06	0.000101	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling by GPCR—IL6—asthma	8.69e-06	0.0001	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ARG2—asthma	8.64e-06	0.0001	CbGpPWpGaD
Sitaxentan—Vomiting—Prednisone—asthma	8.54e-06	5.57e-05	CcSEcCtD
Sitaxentan—Rash—Prednisone—asthma	8.47e-06	5.52e-05	CcSEcCtD
Sitaxentan—Dermatitis—Prednisone—asthma	8.46e-06	5.52e-05	CcSEcCtD
Sitaxentan—EDNRA—Signaling Pathways—POMC—asthma	8.45e-06	9.78e-05	CbGpPWpGaD
Sitaxentan—Headache—Prednisone—asthma	8.41e-06	5.49e-05	CcSEcCtD
Sitaxentan—CYP3A4—Biological oxidations—POMC—asthma	8.39e-06	9.7e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CCL2—asthma	8.27e-06	9.57e-05	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—MMP9—asthma	8.26e-06	9.56e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IL6R—asthma	8.25e-06	9.54e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ALDH7A1—asthma	8.22e-06	9.51e-05	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—PTEN—asthma	8.21e-06	9.5e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—EGFR—asthma	8.09e-06	9.36e-05	CbGpPWpGaD
Sitaxentan—Nausea—Prednisone—asthma	7.98e-06	5.2e-05	CcSEcCtD
Sitaxentan—CYP3A4—Metabolism—LTC4S—asthma	7.91e-06	9.15e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ARG2—asthma	7.88e-06	9.12e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—SERPINE1—asthma	7.72e-06	8.93e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	7.58e-06	8.76e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—RHOA—asthma	7.45e-06	8.61e-05	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—VEGFA—asthma	7.42e-06	8.58e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—NOS3—asthma	7.37e-06	8.53e-05	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—STAT3—asthma	7.35e-06	8.5e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ALOX5AP—asthma	7.16e-06	8.28e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ALOX15—asthma	7.16e-06	8.28e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—asthma	6.91e-06	7.99e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—LTA4H—asthma	6.86e-06	7.93e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CHAT—asthma	6.83e-06	7.9e-05	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—TGFB1—asthma	6.81e-06	7.88e-05	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—EGFR—asthma	6.68e-06	7.72e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—CXCL8—asthma	6.54e-06	7.56e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ALOX5AP—asthma	6.53e-06	7.55e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ALOX15—asthma	6.53e-06	7.55e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IL2—asthma	6.25e-06	7.23e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CHAT—asthma	6.23e-06	7.21e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling by GPCR—IL6—asthma	6.22e-06	7.19e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ALOX5—asthma	6.09e-06	7.04e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ARG1—asthma	5.99e-06	6.93e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—MMP9—asthma	5.91e-06	6.84e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—PTEN—asthma	5.88e-06	6.8e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CARM1—asthma	5.81e-06	6.72e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—DCN—asthma	5.73e-06	6.62e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ALDH2—asthma	5.57e-06	6.44e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ALOX5—asthma	5.55e-06	6.42e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ALDH7A1—asthma	5.42e-06	6.27e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—POMC—asthma	5.36e-06	6.19e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—VEGFA—asthma	5.31e-06	6.14e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GSTT1—asthma	5.3e-06	6.13e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CARM1—asthma	5.3e-06	6.13e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—STAT3—asthma	5.26e-06	6.08e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—DCN—asthma	5.22e-06	6.04e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ARG2—asthma	5.2e-06	6.01e-05	CbGpPWpGaD
Sitaxentan—EDNRB—Signaling Pathways—IL6—asthma	5.13e-06	5.94e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ALDH2—asthma	5.08e-06	5.87e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—asthma	4.88e-06	5.65e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—asthma	4.88e-06	5.65e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—TGFB1—asthma	4.87e-06	5.64e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GSTT1—asthma	4.83e-06	5.59e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—EGFR—asthma	4.78e-06	5.53e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—asthma	4.45e-06	5.15e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—NQO1—asthma	4.4e-06	5.09e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ADCY2—asthma	4.31e-06	4.98e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ALOX5AP—asthma	4.31e-06	4.98e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ALOX15—asthma	4.31e-06	4.98e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—asthma	4.27e-06	4.94e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CHAT—asthma	4.11e-06	4.75e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—NQO1—asthma	4.01e-06	4.64e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ADCY2—asthma	3.93e-06	4.54e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—asthma	3.89e-06	4.51e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—asthma	3.73e-06	4.31e-05	CbGpPWpGaD
Sitaxentan—EDNRA—Signaling Pathways—IL6—asthma	3.67e-06	4.25e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GSTP1—asthma	3.67e-06	4.25e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ALOX5—asthma	3.66e-06	4.24e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—HMOX1—asthma	3.62e-06	4.19e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ITPR1—asthma	3.61e-06	4.18e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—CAT—asthma	3.57e-06	4.13e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CARM1—asthma	3.49e-06	4.04e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—DCN—asthma	3.44e-06	3.98e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—asthma	3.4e-06	3.93e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—GSTM1—asthma	3.37e-06	3.9e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PLA2G4A—asthma	3.37e-06	3.9e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ALDH2—asthma	3.35e-06	3.87e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GSTP1—asthma	3.35e-06	3.87e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—HMOX1—asthma	3.3e-06	3.82e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ITPR1—asthma	3.29e-06	3.81e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—CAT—asthma	3.26e-06	3.77e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GSTT1—asthma	3.19e-06	3.68e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PPP2CA—asthma	3.11e-06	3.59e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PLA2G4A—asthma	3.08e-06	3.56e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—GSTM1—asthma	3.08e-06	3.56e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PPP2CA—asthma	2.83e-06	3.28e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—NQO1—asthma	2.65e-06	3.06e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ADCY2—asthma	2.59e-06	3e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—POMC—asthma	2.39e-06	2.76e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GSTP1—asthma	2.21e-06	2.55e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—HMOX1—asthma	2.18e-06	2.52e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—POMC—asthma	2.17e-06	2.52e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—ALB—asthma	2.17e-06	2.52e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ITPR1—asthma	2.17e-06	2.51e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—CAT—asthma	2.15e-06	2.49e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—NOS3—asthma	2.08e-06	2.41e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PLA2G4A—asthma	2.03e-06	2.35e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—GSTM1—asthma	2.03e-06	2.35e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—ALB—asthma	1.98e-06	2.29e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PTGS2—asthma	1.9e-06	2.2e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—NOS3—asthma	1.9e-06	2.19e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PPP2CA—asthma	1.87e-06	2.16e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PTGS2—asthma	1.73e-06	2.01e-05	CbGpPWpGaD
Sitaxentan—CYP2C19—Metabolism—PTEN—asthma	1.66e-06	1.92e-05	CbGpPWpGaD
Sitaxentan—CYP2C9—Metabolism—PTEN—asthma	1.51e-06	1.75e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—POMC—asthma	1.43e-06	1.66e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—ALB—asthma	1.31e-06	1.51e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—NOS3—asthma	1.25e-06	1.45e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PTGS2—asthma	1.14e-06	1.32e-05	CbGpPWpGaD
Sitaxentan—CYP3A4—Metabolism—PTEN—asthma	9.98e-07	1.15e-05	CbGpPWpGaD
